logo
Select company
Select metric
$ -33.55MEarning Before Interest & Taxes (EBIT)
VS
Market
20
Sector
44
Industry
58
History
30
$ 5.05Close
$ 0.84 - $ 5.94 52-Week Range
Ticker Information

Ticker

GALT

Company Name

GALECTIN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

GALECTIN THERAPEUTICS INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GALT - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -33.55M
3/31/2025$ -38.96M
12/31/2024$ -41.51M
9/30/2024$ -40.41M
6/30/2024$ -43.9M
3/31/2024$ -41.26M
12/31/2023$ -41.89M
9/30/2023$ -43.07M
6/30/2023$ -38.19M
3/31/2023$ -39.1M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • GALECTIN THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT stands at $ -20.66M.
  • Over the past 5 years, GALECTIN THERAPEUTICS INC's average EBIT has been $ -35.07M.
  • The median EBIT for GALECTIN THERAPEUTICS INC during this period was $ -36.09M
  • GALECTIN THERAPEUTICS INC reached its highest EBIT over the past 5 years at $ -20.66M.
  • The lowest EBIT recorded by GALECTIN THERAPEUTICS INC in the same timeframe $ -43.9M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

GALT - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -43.9M

Minimum

Jun 30, 2024

$ -20.66M

Maximum

Sep 30, 2020

$ -35.07M

Average

$ -36.09M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.64M with a standard deviation of $ 130.66M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 442.4M
average$ 28.64M
median$ 897.02K
std$ 130.66M